HPV vaccines 'substantially' reduce cervical cancer risk: study

Cervical cancer, which is caused by HPV—a common sexually transmitted infection—is preventable with reliable and safe vaccines
Cervical cancer, which is caused by HPV—a common sexually transmitted infection—is preventable with reliable and safe vaccines.

Cervical cancer cases plummeted among British women who received a vaccination against the human papillomavirus, according to a study published Thursday.

In comparing cervical cancer and precancer rates before and after an HPV immunization program was introduced in England in 2008, the researchers found a "substantial reduction", especially among the youngest women to have received the jab, according to results published in The Lancet medical journal.

"Our study provides the first direct evidence of the effect of HPV vaccination using the bivalent Cervarix vaccine on cervical cancer incidence," the authors wrote.

The estimated risk reduction was most notable among those who had been vaccinated at the earliest possible ages of 12-13 years old, with an 87 percent drop. Those immunized between ages 16-18 saw a 34 percent dip, the study found.

Cervical cancer, which is caused by HPV—a common sexually transmitted infection—is preventable with reliable and safe vaccines, and also curable if caught early and treated.

Last year, the World Health Organization launched a global strategy to eliminate the disease, which is one of the most common female cancers and kills hundreds of thousands annually.

Cervical cancer
Factfile on cervical cancer.

While the latest study appears to support the broad use of HPV vaccines, uptake and availability of the shots pose an issue, according to a commentary accompanying the results.

"Even in a wealthy country, such as England with to HPV immunization, uptake has not reached the 90% vaccination target of girls aged 15 years set by WHO," wrote gynecologists Maggie Cruickshank and Mihaela Grigore.

"Covid-19 is an additional challenge to delivering HPV vaccination but only adds to a long list, including access to affordable vaccines, infrastructure for low temperature-controlled supply chains, delivery, and ."

The authors of the study also noted several limitations, including that rarely appears in the age group they surveyed—individuals who today are no older than 25—even in the absence of vaccines.

Journal information: The Lancet

© 2021 AFP

Citation: HPV vaccines 'substantially' reduce cervical cancer risk: study (2021, November 4) retrieved 25 June 2024 from https://medicalxpress.com/news/2021-11-hpv-vaccines-substantially-cervical-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Cervical cancer rates stable or trending down in countries with effective screening measures

49 shares

Feedback to editors